HOPPER JONATHAN MARK (Chief Medical Officer) sold 2.4% of their position (1.65K shares) of VERICEL CORP on the open market
Open‑market sale worth $64.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001140361-25-044348
Officer· Chief Medical Officer
Since Feb 2020
+1.65K
Net shares
Net buyer
$64.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.30K acquired · 1.65K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.65K
Price / share
$18.00
Trade value
$29.74K
% of position
2.5%
12/2/2025
66.56K→68.21K
Common Stock
Direct
Shares
−1.65K
Price / share
$39.14
Trade value
$64.66K
% of position
2.4%
12/2/2025
68.21K→66.56K
Total
Net shares
+0.00
Net value
-$34.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2025 | M · Option Exercise | +1.65K | $18.00 | $29.74K | 2.5% | 66.56K | 68.21K |
| Common Stock Direct | 12/2/2025 | S · Sale | −1.65K | $39.14 | $64.66K | 2.4% | 68.21K | 66.56K |
| Total | +0.00 | -$34.92K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.65K shares
Shares
+1.65K
Strike price
18
Held after
7.10K
Exercisable
—
12/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.65K shares | 12/2/2025 | M · Option Exercise | +1.65K | 18 | — | 7.10K |